ecig

Read more about the article <strong>State-of-the-art review article concludes that e-cigarettes may offer health benefits to COPD patients</strong>

State-of-the-art review article concludes that e-cigarettes may offer health benefits to COPD patients

The ground-breaking review article "Health impact of e-cigarettes and heated tobacco products in chronic obstructive pulmonary disease: Current and emerging evidence" published in Expert Review of Respiratory Medicine discusses existing and future options for COPD smokers who have difficulty quitting smoking. It also systematically reviews the current literature about e-cigarettes and heated tobacco products. The article is authored by CoEHAR researchers of the University of Catania together with British respiratory physicians at Guy’s & St Thomas’ Hospitals in London.

Continue ReadingState-of-the-art review article concludes that e-cigarettes may offer health benefits to COPD patients
Read more about the article In Silico review: ecig add no additional cardiovascular health risks

In Silico review: ecig add no additional cardiovascular health risks

The research covered 25 studies comprising 1,810 participants who smoked. The authors found that nearly two thirds of the tests analyzed showed e-cigarettes do not bring any additional harm to a smoker’s health, specifically in relation to heart rate, blood pressure and cardiovascular test. In fact, researchers evaluated evidence from two clinical studies that showed that the use of e-cigarettes could lead to a potential benefit. For example, participants with hypertension experienced a clinically significant reduction in systolic blood pressure after one year of electronic nicotine delivery systems use.

Continue ReadingIn Silico review: ecig add no additional cardiovascular health risks
Read more about the article Polosa inaugurates 2023 with 2 new records

Polosa inaugurates 2023 with 2 new records

A record that is associated with another incredible scientific result of the CoEHAR team which closes 2022 with a record: the group of scientists affiliated with the research center in Catania has managed to achieve, in just 4 years, 128 scientific publications in prestigious journals dedicated to Harm Reduction.

Continue ReadingPolosa inaugurates 2023 with 2 new records
Read more about the article <strong>Anti-vaping narrative driven by low quality science goes undetected by editorial quality checks</strong>

Anti-vaping narrative driven by low quality science goes undetected by editorial quality checks

In their Commentary “A tale of flawed e-cigarette research undetected by defective peer review process” published in Internal and Emergency Medicine, top harm reduction researchers Riccardo Polosa, Founder of the CoEHAR, and Konstantinos Farsalinos, from University of West Attica, denounce the danger of an escalation in the promotion and dissemination of an anti-vaping narrative supported by evidence of the lowest quality.

Continue ReadingAnti-vaping narrative driven by low quality science goes undetected by editorial quality checks
Read more about the article The economy of harm reduction: the effects of vaping taxation

The economy of harm reduction: the effects of vaping taxation

In the field of the economic implications of vaping products, Michael Pesko is among the leading experts: health economist and Associate Professor in the Department of Economics at Georgia State University, dr. Pesko is particularly interested in policy changes affecting the use of e-cigarettes. In this article, we provide a synthesis of his work on the economic impact of government and policy makers choices in the vaping market.

Continue ReadingThe economy of harm reduction: the effects of vaping taxation
Read more about the article Motore Sanità: risk reduction as a public health strategy 

Motore Sanità: risk reduction as a public health strategy 

Riccardo Polosa: "In Italy, even today, we don't have a health policy that takes care of these people. Risk reduction represents the solution, an extraordinary opportunity for change and acceleration in terms of individual and public health. I consider it serious to insist on hiding from citizens the real opportunities offered by potentially low-risk instruments, even pointing them out as dangerous on a par with conventional cigarettes. 

Continue ReadingMotore Sanità: risk reduction as a public health strategy 
Read more about the article New frontiers in the care of people with schizophrenia: low-risk products are a valid substitute for smoking

New frontiers in the care of people with schizophrenia: low-risk products are a valid substitute for smoking

According to a qualitative analysis that involved the health personnel responsible for accompanying patients with schizophrenic spectrum disorders in their therapeutic paths, tobacco addiction is highly harmful and widespread among patients suffering from these disorders: doctors, psychologists and healthcare professionals in general have a positive view of smokeless instruments, which are considered an excellent substitute for smoking.

Continue ReadingNew frontiers in the care of people with schizophrenia: low-risk products are a valid substitute for smoking